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l e t t e r s
Trp53 loss of function has previously been shown to rescue tissue maintenance and developmental defects resulting from DNA damage or DNA-repair gene mutations [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] . Here, we report that p53 deficiency severely exacerbates tissue degeneration caused by mosaic deletion of the essential genome maintenance regulator Atr. Combined loss of Atr and p53 (Trp53 −/− Atr mKO ) led to severe defects in hair follicle regeneration, localized inflammation (Mac1 + Gr1 + infiltrates), accelerated deterioration of the intestinal epithelium and synthetic lethality in adult mice. Tissue degeneration in Trp53 −/− Atr mKO mice was characterized by the accumulation of cells maintaining high levels of DNA damage. Moreover, the elevated frequency of these damaged cells in both progenitor and downstream compartments in Trp53 −/− Atr mKO skin coincided with delayed compensatory tissue renewal from residual ATR-expressing cells. Together, our results indicate that the combined loss of Atr and Trp53 in adult mice leads to the accumulation of highly damaged cells, which, consequently, impose a barrier to regeneration from undamaged progenitors.
Tissue development, homeostasis and renewal are strongly influenced by processes that limit the accumulation of damaged, unproductive cells. Through its functions in cell cycle regulation and apoptosis, the p53 transcription factor plays a central role in these processes, particularly in response to DNA damage. For example, in numerous mouse models, the developmental arrest, tissue homeostatic failures and premature cellular senescence caused by DNA repair gene mutation are partially rescued by Trp53 deficiency [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] . Furthermore, p53 pathway hyperactivation leads to tissue deterioration and promotes the appearance of several age-associated pathologies in mice 13, 14 , indicating that unregulated p53 engagement can present a substantial barrier to tissue renewal. However, mice expressing additional copies of Trp53 and Cdkn2a (encoding Cdkn2a, also called Arf) under normal regulatory control (s-Arf/p53 mice) show enhanced antioxidant gene expression, decreased accumulation of mutated cells and a significantly extended lifespan 15 . This study and others have indicated that augmented p53 pathway activity may enhance tissue renewal by reducing levels of reactive oxygen species 15 and by limiting the accumulation of damaged cells that impede repopulation from competent progenitors [15] [16] [17] [18] .
Deletion of the ATR checkpoint kinase leads to an increase in double-strand break formation in the course of normal DNA replication [19] [20] [21] [22] and to the activation of p53 (Supplementary Fig. 1) . Previously, we have demonstrated that such deletion in the presence of wild-type p53 leads to the rapid elimination of Atr-deleted (Atr ∆/-) cells from adult tissues that maintain high rates of cellular proliferation; however, cellularity in most tissues is quickly restored by concomitant regeneration from progenitors that have escaped Atr deletion 23 . Despite this initial reconstitution, Atr-mosaic knockout (Atr mKO ) mice ultimately fail to maintain tissue homeostasis and age prematurely 23 . In light of the proposed functions for p53 in tissue homeostasis, p53 activation in Atr mKO mice could drive acute tissue degeneration by reducing cellularity or, alternatively, could facilitate immediate regeneration by limiting the accumulation of damaged cells, thus promoting renewal from undamaged progenitors.
To investigate these models, systemic mosaic deletion of Atr in Trp53 +/+ and Trp53 −/− mice was performed as described previously 23 by tamoxifen (TAM)-induced acute activation of a ubiquitously expressed form of Cre recombinase (UBC-Cre-ERT2). The rates of Cre-mediated loxP recombination of the Atr flox allele were identical regardless of Trp53 status, as demonstrated by equivalent Atr flox recombination rates in the brain, bone marrow and intestines of Atr flox/+ (Atr mHet ) control mice and by deletion rates in the brains of Atr flox/-(Atr mKO ) mice (Fig. 1) , a tissue in which Atr-null cells show no selective disadvantage over time 23 . Consistent with previous studies 23 , a rapid deterioration of the intestinal epithelium was observed in Atr mKO mice 6 d after TAM treatment (Fig. 1) , with deterioration reaching a nadir a few days later (7-14 d after TAM treatment, ref. 23 ). This degeneration coincided with a 28% mortality of Atr mKO animals within 2 weeks of Atr deletion (Fig. 1a) , after which time compensatory tissue renewal from residual ATR-expressing progenitors allowed Atr mKO mice to survive similar to controls for up to 1 year 23 .
Remarkably, absence of Trp53 did not prevent short-term mortality following Atr mosaic deletion but instead led to an accelerated and highly penetrant lethal phenotype, with more than 94% of Trp53 −/− Atr mKO mice dying within 2 weeks (median, 8 d) of TAM treatment (Fig. 1a) . The single surviving Trp53 −/− Atr mKO mouse in these studies had an abnormally low deletion rate (60% brain deletion). However, this mouse showed hair graying within 1 month of TAM treatment (Fig. 1b) , a phenotype observed in Trp53 +/+ Atr mKO mice l e t t e r s only at substantially later time points (3-6 months) 23 . Furthermore, histological analysis of mice killed 6 d after TAM (just before the median mortality) revealed that the absence of Trp53 failed to rescue acute bone marrow degeneration and exacerbated the acute deterioration of the intestinal epithelium observed in Atr mKO mice ( Fig. 1c-e) . Consistent with ATR's essential role during DNA replication [19] [20] [21] [22] , decreased cellularity in the bone marrow was primarily attributable to the loss of highly proliferative populations (myeloid) rather than largely quiescent subsets (T cells, Fig. 1d ). Synthetic lethality and regenerative deficiencies were also observed in Trp53 −/− Atr mKO mice under conditions of decreased TAM treatment and lower-than-average deletion rates (Fig. 1b and data not shown) . These data indicate that Trp53 deficiency fails to rescue acute bone marrow and intestinal degeneration seen in Atr mKO mice and that Trp53 is required for organismal survival following Atr deletion. 
e t t e r s
The multiple checkpoint defects conferred by Atr and Trp53 loss (ATR, S/G2; p53, G1) may permit redundant or aberrant S phase entry and additive genome destabilization. Indeed, a synthetic-lethal interaction between Atr-Chk1 pathway inhibition and Trp53 deficiency is observed in cultured cells (refs. 24-26 and data not shown). However, accelerated depletion of Atr-deleted cells did not appear to be the primary cause of tissue failure in Trp53 −/− Atr mKO mice, as Atr ∆/-cells were represented at similar or higher frequencies in the intestines and bone marrow of these mice compared to Atr mKO mice (Fig. 1f) . In addition, mitotic spreads from freshly isolated Trp53 −/− Atr mKO bone marrow showed mild and extensive chromatid breaks at an elevated frequency and at a significantly increased severity (P = 0.01, Supplementary Fig. 2 ). Such levels of genomic instability in the absence of exogenous DNA-damaging treatments are hallmarks of Atr deletion [19] [20] [21] [22] . Together, these data indicate that tissue homeostasis in Trp53 −/− Atr mKO mice is compromised despite the continued presence of Atr ∆/-cells.
Atr deletion leads to marked increases in genomic instability during DNA synthesis, resulting in H2AX phosphorylation (γH2AX) 20, 21 . Of note, the frequency of cells exhibiting H2AX phosphorylation in the bone marrow and intestines of Trp53 −/− Atr mKO mice was greatly increased compared to Atr mKO controls (Fig. 2) . γH2AX staining in the bone marrow was most prominent in cells with aberrantly large nuclei, which were morphologically distinguishable from multinucleated megakaryocytes or condensed apoptotic bodies (Fig. 2a) . Indeed, p53-independent apoptosis (cleaved caspase-3 staining) was observed in minority fractions of γH2AX-positive cells in both the bone marrow and the intestines of Trp53 −/− Atr mKO mice (Fig. 2c,f) , leading to insignificant increases in total numbers of apoptotic cells ( Supplementary  Fig. 3c ). Given that Atr ∆/-cells were maintained at high levels in both of these tissues (Fig. 1f) , these data are consistent with Trp53 deficiency permitting the accumulation of Atr ∆/-cells that have acquired DNA damage in the course of expansion.
Previous studies have indicated that tissue maintenance following acute mosaic deletion of Atr is dependent on compensatory renewal from cells that have escaped loxP recombination and continue to express ATR 23 . We sought to directly investigate whether the increased abundance of DNA-damaged cells in Trp53 −/− Atr mKO mice detrimentally affects this regenerative response. To accurately monitor the process of regeneration and circumvent the lethality associated with combined systemic Atr and Trp53 deletion, we studied the effect of localized Atr deletion on depilation-induced hair follicle regeneration in the skin. Localized Atr deletion was accomplished through topical treatment with 4-hydroxytamoxifen (4-OHT) while hair follicles were in telogen (resting) phase. Four days after cessation of 4-OHT treatment, hair follicle regeneration was synchronously induced by depilation (plucking) of the hair shafts in the central portion of a larger 4-OHT treatment region. 
l e t t e r s l e t t e r s
As previously described, only a short delay in hair regeneration (3-4 d) was observed in Atr mKO skin in comparison to Atr mHet controls following a single round of depilation (ref. 23 and data not shown). In sharp contrast, hair regeneration in Trp53 −/− Atr mKO skin was severely delayed compared to that in Atr mKO skin, as demonstrated by both shaft regeneration (Fig. 3a) and formation of the hair follicle bulb (Fig. 3b) . Closer examination of Trp53 −/− Atr mKO skin revealed distinct malformations of the epithelium, root sheath and hair bulb, each characterized by the presence of aberrant cells with enlarged nuclei (Fig. 3b) . Notably, after hair shaft regeneration, an increased abundance of gray hair was observed in Trp53 −/− Atr mKO skin in both the depilated region and the surrounding Atr-deleted region (Fig. 3c) ; this increase far exceeded that observed after a single round of depilation in Atr mKO skin (Fig. 3a and ref. 23) . These results indicate that the combined loss of Atr and Trp53 markedly impedes hair follicle renewal and leads to long-term deficiencies in regenerated hair shafts (hair graying).
The short-term regenerative defect observed in Trp53 −/− Atr mKO skin was accompanied by a severe inflammatory response characterized by reddening, exfoliation and the recruitment of Gr1 + Mac1 + innate immune cells (Fig. 3a,d) . Inflammation initially occurred at the depilated area and spread outwardly to eventually cover the larger Atr-deleted (4-OHT-treated) region (Fig. 3a) . This phenotype was not observed in Atr mKO or Atr mHet controls (Fig. 3a,d and ref. 23 ). To determine whether delayed follicle regeneration in Trp53 −/− Atr mKO skin was a consequence of the acute inflammation, the topical immunosuppressant dexamethasone (dex) was applied 4 d after depilation and continued subsequently. This treatment was sufficient to prevent skin reddening and inhibit Gr1 + Mac1 + innate immune cell infiltration into Trp53 −/− Atr mKO epithelium and did not affect hair follicle generation in controls (Fig. 3d and Supplementary Fig. 4) . However, dex treatment did not rescue hair follicle regeneration in Trp53 −/− Atr mKO skin ( Fig. 3e and Supplementary Fig. 4) . Notably, cessation of dex treatment 22 d after depilation in Trp53 −/− Atr mKO skin was immediately followed by a severe inflammatory response ( Supplementary  Fig. 4) , indicating that the cause of inflammation in Trp53 −/− Atr mKO skin continued to be present in the tissue for up to 3 weeks after depilation. In summary, although it is possible that innate immune infiltration and the gross pathological effects of inflammation in Trp53 −/− Atr mKO skin may ultimately affect tissue maintenance in some manner (for example, hair graying), they do not appear to be the primary cause of short-term delays in hair follicle regeneration.
To assess original Atr deletion rates before depilation and quantify the representation of Atr ∆ cells during follicle regeneration, the recombination status of the Atr flox allele was determined before depilation (day 0) and at 4 and 8 d after depilation. The frequencies of Atr ∆ cells (either Atr ∆/+ or Atr ∆/-) were similar in all genotypes both before depilation (day 0) and in early anagen phase (day 4, Fig. 4a) . These results indicate that deletion rates (approximating 90% in the epithelium) were unaffected by Trp53 status before depilation. Although the frequencies of Atr ∆/-cells were similar in Atr mKO and Trp53 −/− Atr mKO skin in early anagen, these frequencies decreased significantly (P = 0.0003) later in anagen (day 8, Fig. 4a ). Similar to other tissues (Fig. 1f) , this decline was not accentuated by Trp53 deficiency (Fig. 4a) , indicating that the regenerative delay in Trp53 −/− Atr mKO skin occurred despite the continued maintenance of Atr ∆/-cells.
We hypothesized that the regenerative defect in Trp53 −/− Atr mKO skin may be caused by the persistent accumulation of highly damaged Atr ∆/-cells, which would continue to occupy functional space and impede regeneration from residual ATR-expressing progenitors. To investigate this possibility, γH2AX-positive cells were quantified in the general epithelium and in CD34 + α 6 -integrin + stem and progenitor cells, which are among the earliest populations of cells to proliferate and contribute to hair follicle renewal [27] [28] [29] . In early anagen (day 4), the abundance of γH2AX-positive cells was increased similarly in Atr mKO and Trp53 −/− Atr mKO skin, both in progenitor populations and in the general epithelium (Fig. 4b-d) . Therefore, p53 function does not strongly influence the generation of damaged Atr ∆/-cells soon after exiting quiescence. However, at later stages of hair follicle regeneration (day 8), the frequency of γH2AX-positive cells significantly declined in Atr mKO skin and was maintained only in Trp53 −/− Atr mKO skin volume 41 | number 10 | october 2009 Nature GeNetics l e t t e r s (Fig. 4c,d) . Notably, continued proliferation during differentiation from progenitors may amplify differences in the frequency of γH2AX-positive cells between Atr mKO and Trp53 −/− Atr mKO skin (Fig. 4c,d ). γH2AX-positive cells showed enlarged nuclei that were morphologically distinct from those of apoptotic cells, which was consistent with the low frequency of cells staining positive for cleaved caspase-3 ( Supplementary Fig. 5 ). These data indicate that Atr deletion in the absence of Trp53 leads to the persistent accumulation of genetically unstable Atr ∆/-cells. We then examined whether the accrual of γH2AX-positive cells in Trp53 −/− Atr mKO skin was associated with defective compensatory renewal from residual cells that escaped Atr deletion. Consistent with the results of previous studies 23 , a large fraction of Atr mKO hair follicles began to develop hair bulbs within 8 d of depilation (Fig. 5) . These bulbs maintained active cellular proliferation (as detected by nuclear PCNA staining) and were largely comprised of cells that escaped Atr deletion and continued to express the ATR-ATRIP complex (Fig. 5) . In contrast, Trp53 −/− Atr mKO skin largely failed to undergo compensatory regeneration, as indicated by the absence of cellular proliferation in the hair bulb and the lack of expansion of ATR-ATRIP-positive cells (Fig. 5) . These data indicate that the compensatory renewal driven by residual ATR-expressing cells is strongly impeded in Trp53 −/− Atr mKO skin.
Previously, we have shown that Atr-deleted cells are rapidly eliminated from proliferative tissues and replaced through compensatory renewal by undeleted, Atr-expressing progenitors 23 .
The studies described here demonstrate that p53 limits the accumulation of highly damaged cells following mosaic Atr deletion and indicate that loss of this constraint delays tissue regeneration. These results strongly support the theory that p53 plays a key role in maintaining adult tissue homeostasis by preventing functionally compromised cells from acting as a barrier to progenitor-driven renewal [15] [16] [17] [18] . Occupancy of tissues by genetically unstable cells might delay tissue renewal either by obstructing competent progenitors from interacting with key environmental cues or by causing the generation of secreted factors [30] [31] [32] that inhibit renewal. Such mechanisms may operate as a tissue homeostatic checkpoint, delaying regeneration until damaged cells have been effectively cleared.
The degeneration of tissue integrity following combined loss of Atr and Trp53 is somewhat unexpected, given that Trp53 deficiency generally attenuates the effects of mutations in other genome maintenance regulators [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] . Although Trp53 loss may be sufficient to accommodate lesser degrees of genomic instability and permit mildly damaged cells to functionally contribute to tissue homeostasis, it is likely that the severe cell cycle and genome destabilizing effects of Atr deficiency are not alleviated by p53's absence but, rather, are exacerbated by it. According to this model, replication fork instability in concert with near-complete loss of cell cycle checkpoint functions caused by a lack of ATR and p53 might allow redundant or aberrant S phase entry, leading to further instability and the inappropriate propagation of terminally damaged cells. Indeed, the persistent accumulation of genetically unstable cells in Trp53 −/− Atr mKO tissues compared to Trp53 wild-type Atr mKO controls supports this model (Fig. 2, Fig. 4c,d and Supplementary Fig. 2) . Therefore, in addition to supporting a general function for p53 in facilitating regeneration of adult tissues, this study provides the first evidence of a specific synthetic interaction between ATR and p53 inhibition in adult mammals. These results suggest that ATR-Chk1 inhibitors may be uniquely useful for the treatment of Trp53-deficient cancers by causing synergistic increases in genomic instability, which may consequentially inhibit regeneration from undamaged bystanders. 
